Literature DB >> 16771624

Influence of pharmacokinetics/pharmacodynamics of antibacterials in their dosing regimen selection.

Francesco Scaglione1, Luca Paraboni.   

Abstract

The choice of antimicrobial dosing in clinical practice in the past was based upon a 'penicillin mentality', that is, on the assumption that the in vivo antimicrobial efficacy is dependent on the duration of drug levels above the minimum inhibitory concentration of target microorganisms. Really, a rational antimicrobial therapy is strongly related to a basic understanding of the influence the patient has on the antibiotic (pharmacokinetics [PKs]) and the patient's response to the specific drug effects (pharmacodynamics [PDs]). PK/PD parameters are essential in facilitating the translation of microbiological activity into clinical situations, ensuring a successful outcome. This review will analyze the typical patterns of antimicrobial activity and the corresponding PK/PD parameters, with a special focus on a PK/PD dosing approach with the most commonly utilized antimicrobial agent classes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16771624     DOI: 10.1586/14787210.4.3.479

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  15 in total

1.  Blood, tissue, and intracellular concentrations of erythromycin and its metabolite anhydroerythromycin during and after therapy.

Authors:  S Krasniqi; P Matzneller; M Kinzig; F Sörgel; S Hüttner; E Lackner; M Müller; M Zeitlinger
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

2.  Pharmacokinetic-pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries.

Authors:  A Canut; A Isla; C Betriu; A R Gascón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-28       Impact factor: 3.267

3.  Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers.

Authors:  Mario Del Tacca; Giuseppe Pasqualetti; Antonello Di Paolo; Agostino Virdis; Gabriele Massimetti; Giovanni Gori; Daniele Versari; Stefano Taddei; Corrado Blandizzi
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

4.  An optimized method for the detection and spatial distribution of aminoglycoside and vancomycin antibiotics in tissue sections by mass spectrometry imaging.

Authors:  Ning Wang; Véronique Dartois; Claire L Carter
Journal:  J Mass Spectrom       Date:  2021-03       Impact factor: 1.982

Review 5.  Clinical Pharmacology of Antibiotics.

Authors:  Rachel F Eyler; Kristina Shvets
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-12       Impact factor: 8.237

6.  Population pharmacokinetics and pharmacodynamics of sitafloxacin in patients with community-acquired respiratory tract infections.

Authors:  Yusuke Tanigawara; Mitsuo Kaku; Kyoichi Totsuka; Hiroyuki Tsuge; Atsushi Saito
Journal:  J Infect Chemother       Date:  2013-03-26       Impact factor: 2.211

Review 7.  A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis.

Authors:  Véronique Dartois; Clifton E Barry
Journal:  Bioorg Med Chem Lett       Date:  2013-07-12       Impact factor: 2.823

Review 8.  Drug permeation and metabolism in Mycobacterium tuberculosis: Prioritising local exposure as essential criterion in new TB drug development.

Authors:  Lloyd Tanner; Paolo Denti; Lubbe Wiesner; Digby F Warner
Journal:  IUBMB Life       Date:  2018-06-22       Impact factor: 3.885

9.  Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents.

Authors:  Suresh B Lakshminarayana; Tan Bee Huat; Paul C Ho; Ujjini H Manjunatha; Véronique Dartois; Thomas Dick; Srinivasa P S Rao
Journal:  J Antimicrob Chemother       Date:  2014-11-11       Impact factor: 5.758

Review 10.  Antimicrobial dosing in critically ill patients with sepsis-induced acute kidney injury.

Authors:  Anish Kumar; Narinder Pal Singh
Journal:  Indian J Crit Care Med       Date:  2015-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.